ALBANY, N.Y., Aug. 26, 2014 /PRNewswire/ — Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the Morgan Stanley Global Healthcare Conference o…
Leading Global Industry Trends, Lighting up the China Pharmaceutical Dream
SHANGHAI, Aug. 26, 2014 /PRNewswire/ — CPhI, ICSE & BioPh China 2014 and P-MEC, InnoPack…
BOSTON, August 25, 2014 /PRNewswire/ — Raiing Medical Company and the Center for Connected Health at Partners HealthCare initiated a clinical research program to assess the feasibility of the iThermonitor as a clinical support tool in the m…
Ebola has come to the DRC. “Two out of eight cases tested in an outbreak of deadly fever in the northwest of the Democratic Republic of Congo were positive for the Ebola virus, the central African nation’s health minister confirmed on Sunday.”The results are positive. The Ebola virus is confirmed in DRC,” Felix Kabange Numbi said, referring to samples taken from people infected with the previously unidentified fever that has killed dozens since mid-August. The World Health Organization (WHO) announced on Thursday that 70 people had died in an outbreak of hemorrhagic gastroenteritis. A WHO spokesman said the outbreak was not Ebola. DRC is now the fifth African nation to confirm cases of the Ebola outbreak, which began in March. A total of 2,617 infections and 1,427 deaths have been recorded, including in Sierra Leone, Liberia, Guinea and Nigeria. Liberia has seen the most deaths, at more than 600, with the disease confirmed in all regions of the country.” (DW http://bit.ly/1tzIMrw )
Libya on the Brink…The country’s main international airport has been overrun by Islamist militants. “The Islamist groups, led by a militia from the western city of Misrata under the umbrella of “Operation Dawn,” said they had captured the airport in Tripoli on Saturday after more than a month of fighting against the liberal Zintan militias, who have been assigned by the government to guard the airport since 2011…Neighboring Egypt is set to host a regional meeting on Monday to discuss the Libyan crisis. The meeting is expected to include foreign ministers from Egypt, Libya, Tunisia, Algeria, Sudan and Chad, as well as representatives of the Arab League and the African Union’s envoy to Libya.” (LAT http://lat.ms/1tI3rbM)
A Royal Air Force plane carrying a British healthcare worker who contracted Ebola in Sierra Leone – the first Briton to catch the deadly virus – took off from the capital Freetown on Sunday bound for Britain. (Reuters http://bit.ly/XKjE6G)
When disaster strikes a poor country, aid workers from all over the world normally flood the zone. This time, fear of the virus is keeping experts from answering West Africa’s calls for help. (NPR http://n.pr/1qadFkI)
The Philippines is pulling out almost 3,500 workers from three West African states due to the Ebola outbreak, the foreign ministry said on Sunday, a day after Filipino troops in Liberia were ordered to go home. (Reuters http://bit.ly/1qae3zO)
Sierra Leone’s parliament has made the harbouring of Ebola victims a crime punishable by two years’ jail in an attempt to stop the spread of the deadly virus, the justice minister said. (Reuters http://bit.ly/XKjXOX)
A meeting of African health ministers scheduled for early September in Benin has been postponed because of the Ebola epidemic, an official said Sunday. http://yhoo.it/XKlDrz
The worst-ever outbreak of the Ebola virus is taking a heavy toll on west Africa’s economy as crops rot in the fields, mines are abandoned and goods cannot get to market. http://yhoo.it/XKlHrq
Amnesty International is accusing Mali of holding children accused of belonging to armed militias in Mali and participating in the country’s ongoing unrest in jails and being held alongside adults. (ABC http://abcn.ws/1tI3HYv)
A member of an East African regional body monitoring a ceasefire in South Sudan died of a heart attack after some monitors were detained by rebels to the north of the country, further complicating a peace process. (Reuters http://bit.ly/1qaehXy)
Niger’s agriculture minister has been arrested on suspicion of involvement in a baby-trafficking network, a spokesman for his political party and legal sources said. (Reuters http://bit.ly/1qaetGq)
Israeli Prime Minister Benjamin Netanyahu warned Palestinian civilians on Sunday to leave immediately any site where militants are operating, one day after Israel flattened a 13-storey apartment block in Gaza. (Reuters http://reut.rs/1tI3PXM)
The US government says an American held hostage for about two years by an al-Qaida-linked group in Syria has been released. (AP http://bit.ly/1tI4kkR)
In a country where civil liberties remain the prerogative of the powerful and wealthy, the Lebanese gay scene is to be treaded carefully. The recent arrest of 27 members of the LGBT community shows that those not so lucky – those belonging to the more vulnerable tranches of society – are always at risk. (IPS http://bit.ly/1qadXbe)
Italy’s maritime search and rescue service saved 3,500 migrants and found 19 corpses in the Mediterranean since Friday as thousands attempted to cross to Europe by boat over the weekend, the Italian navy said. (Reuters http://bit.ly/1qaeave)
The authorities in Xinjiang, the ethnically divided region in far western China, said on Saturday that eight people had been executed on charges related to separatist violence, including an attack last year in which a car plowed through tourists near Tiananmen Square in Beijing and erupted in flames. (NYT http://nyti.ms/1tI45Gp)
In Sri Lanka’s poverty-stricken Northern Province, residents say they must stretch the few resources they have in order to survive. (IPS http://bit.ly/1qadSV8)
A new UN report points to a sharp increase in numbers of boat people mostly from Myanmar and Bangladesh. Activists fear a further surge of refugee boat people, especially ethnic Rohingya fleeing squalid refugee camps and persecution in Myanmar. (VOA http://bit.ly/XKkzUw)
Venezuela used to be a world leader in managing malaria, but is now the only country in Latin America where incidence of the disease is increasing. Around 75,000 people were infected last year, and according to government figures, 60% of cases were in Sifontes, a tiny region of the country where gold mining – where workers drill for gold in mosquito-friendly standing water – is booming, and healthcare is scarce. (BBC http://bbc.in/1qaeFFx)
The Islamic State’s media logic (The Interpreter http://bit.ly/1sltTar)
A New Focus on Peaceful Conflict Resolution at the UNSC? (UN Dispatch http://bit.ly/1slupoD)
Development blog: Does Banning Child Marriage Really Work? (CGD http://bit.ly/1sluzMT)
A Bold New Way of Measuring A Country’s REAL Wealth (UN Dispatch http://bit.ly/1AL9Wie)
Conflict and disaster reporting: Does the public still care? (ODI http://bit.ly/1AL9ZKQ)
If It Looks Corrupt, It Is Corrupt (Global Anticorruption Blog http://bit.ly/XKofpz)
Win $20,000 to be part of the problem? (Chris Blattman http://bit.ly/1ALadBZ)
Which is more important – changing policies, or changing social norms and behaviours (and how are they connected)? (From Poverty to Power http://bit.ly/1ALakx8)
A Storm in a Bucket: Lessons from the Ice Bucket Challenge Controversy (Policy Innovations http://bit.ly/XKoEbla
HONG KONG, Aug. 25, 2014 /PRNewswire/ — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed that Magnum Opus International Holdings Limited (“Magnum”), a private vehicle that is controlled by CCBC Chairman Mr. Yuen KAM and involves the CCBC management team, together with Cordlife Group Limited (“Cordlife”), a Singapore listed company and substantial shareholder of the Company, have agreed to purchase the Company’s outstanding 7% senior convertible note due 2017 (the “Note”) held by Golden Meditech Holdings Limited (“Golden Meditech”), CCBC’s parent company, for a total consideration of approximately $88.1 million.
The Note was originally issued by the Company to Golden Meditech in 2012 with an aggregate principal amount of $50 million. Magnum and Cordlife are each obligated to purchase 50% of the Note, subject to customary closing conditions and satisfaction of all relevant approvals and consents, including but not limited to the approval of Golden Meditech’s independent shareholders.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
About Magnum Opus International Holdings Limited
Magnum Opus International Holdings Limited is incorporated in the British Virgin Islands. It is controlled by Mr. Yuen KAM, CCBC’s chairman of the Board, and involves the CCBC management team. Mr. Yuen KAM is also the Chairman and Chief Executive Officer of Golden Meditech.
About Cordlife Group Limited (Bloomberg stock code: CLGL SP)
Incorporated in May 2001, Cordlife Group Limited is a multi-product healthcare company catering to the mother and child segment and a leading cord blood and umbilical cord lining banking services provider. Today, Cordlife operates the largest private cord blood banks in each of Singapore, the Philippines and Indonesia, and is amongst the top three market leaders in Hong Kong and India. Cordlife also holds approximately 10.02% and 31.81% stakes in China Cord Blood Corporation and StemLife Berhad respectively, both of which are their countries’ largest cord blood bank operators. For more information, please visit www.cordlife.com.
 Source : Deloitte & Touche Financial Advisory Services Limited report, 10 April 2013
Safe Harbor Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the U.S. Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Mr. Bill Zima
Tel: (+86) 10-6583-7511 (China) or (+1) 646-405-5185 (U.S.)
BEIJING, August 25, 2014 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its wholly-owned subsi…
HONG KONG, Aug. 25, 2014 /PRNewswire/ — Golden Meditech Holdings Limited (the “Company” or “Golden Meditech”, 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, announced that it has entered into an agreement to sell its 7% senior convertible note due 2017 in an aggregate principal amount of US$50 million issued on 3 October 2012 by China Cord Blood Corporation (“CCBC”), a non-wholly-owned subsidiary of the Company (“Convertible Note”) to Magnum Opus International Holdings Limited (“Magnum”) and Cordlife Group Limited (“CGL”) for approximately US$88,090,000 (equivalent to approximately HK$682,697,500) in cash (the “Disposal”). Upon completion of the Disposal, each of Magnum and CGL will hold 50% of the Convertible Note.
Magnum is a private vehicle controlled by Mr. Kam Yuen, Chairman and Chief Executive Officer of the Company and Chairman of CCBC, and involves the CCBC management team. CGL is a cord blood banking services operator listed on the main board of the Singapore Exchange Securities Trading Limited, which currently owns approximately 10% of the issued shares of CCBC.
Following completion of the Disposal, Golden Meditech’s shareholding in CCBC will remain unchanged at approximately 42.0% and will only be diluted to approximately 33.9% if both Magnum and CGL exercise their rights to convert their Convertible Note into CCBC shares and, accordingly, their respective shareholdings in CCBC would increase by approximately 9.7%.
With mainland China’s healthcare sector continues to be driven by the government’s healthcare reform, Golden Meditech believes the Disposal would strengthen its financial position and liquidity, enhancing its ability to fund its potential acquisitions or expansion of its existing healthcare related businesses in mainland China.
The transaction is subject to Golden Meditech and CGL obtaining all relevant approvals and consents, including but not limited to the approval of Golden Meditech’s independent shareholders. An Extraordinary General Meeting (“EGM”) will be convened to consider and approve the transaction and a circular containing details of the Disposal and a notice of EGM are expected be dispatched to the shareholders no later than 16 September 2014.
About Golden Meditech Holdings Limited
Golden Meditech Holdings Limited (www.goldenmeditech.com) is China’s leading integrated-healthcare enterprise. Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets, including cord blood stem cells storage and hospital management, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China’s healthcare industry both through organic growth and strategic expansion.